gabapentin

Generic: gabapentin

Labeler: stallion laboratories private limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler stallion laboratories private limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 300 mg/1

Manufacturer
STALLION LABORATORIES PRIVATE LIMITED

Identifiers & Regulatory

Product NDC 72737-006
Product ID 72737-006_30d4f239-f37b-4b6e-b25e-043a33489011
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219319
Listing Expiration 2026-12-31
Marketing Start 2025-08-07

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72737006
Hyphenated Format 72737-006

Supplemental Identifiers

RxCUI
310430 310431 310432
UPC
0372737007028 0372737006021 0372737005024
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA219319 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (72737-006-01)
  • 100 CAPSULE in 1 BOTTLE (72737-006-02)
  • 500 CAPSULE in 1 BOTTLE (72737-006-03)
  • 1000 CAPSULE in 1 BOTTLE (72737-006-04)
source: ndc

Packages (4)

72737-006-01 30 CAPSULE in 1 BOTTLE (72737-006-01) 72737-006-02 100 CAPSULE in 1 BOTTLE (72737-006-02) 72737-006-03 500 CAPSULE in 1 BOTTLE (72737-006-03) 72737-006-04 1000 CAPSULE in 1 BOTTLE (72737-006-04)

Ingredients (1)

gabapentin (300 mg/1)

Linked Drug Pages (1)

GABAPENTIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "30d4f239-f37b-4b6e-b25e-043a33489011", "openfda": {"nui": ["N0000008486"], "upc": ["0372737007028", "0372737006021", "0372737005024"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["STALLION LABORATORIES PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (72737-006-01)", "package_ndc": "72737-006-01", "marketing_start_date": "20250807"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (72737-006-02)", "package_ndc": "72737-006-02", "marketing_start_date": "20250807"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (72737-006-03)", "package_ndc": "72737-006-03", "marketing_start_date": "20250807"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (72737-006-04)", "package_ndc": "72737-006-04", "marketing_start_date": "20250807"}], "brand_name": "GABAPENTIN", "product_id": "72737-006_30d4f239-f37b-4b6e-b25e-043a33489011", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72737-006", "generic_name": "GABAPENTIN", "labeler_name": "STALLION LABORATORIES PRIVATE LIMITED", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA219319", "marketing_category": "ANDA", "marketing_start_date": "20250807", "listing_expiration_date": "20261231"}